Quest Diagnostics Incorporated (DGX) is a Healthcare stock trading at $194.97 (as of 2026-06-18), with a market capitalization of $21.57B and a trailing P/E of 22.4. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Quest Diagnostics Incorporated provides diagnostic testing along with diagnostic information and related services, delivering routine and advanced clinical testing and anatomic pathology services through its laboratory and patient service network. Services are offered under the Quest Diagnostics brand and other company brands to patients and healthcare organizations, and the company also supports risk assessment for the life insurance industry.